Iwaki Co. Ltd. AI Stock Analysis
Want to see JP:6237 full AI Analyst Report?
Iwaki Co. Ltd. (6237) AI Stock Analysis
Iwaki Co. Ltd.
(TSE/TYO:6237)
The overall score of 70 is heavily driven by Iwaki Co. Ltd.'s exceptional balance sheet stability and reliable top-line growth. While the valuation remains fair for the sector, near-term technical weakness and bearish momentum indicators restrict the stock from achieving a higher rating.
Iwaki Co. Ltd. (6237) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 86.40B
- Dividend Yield
- 2.23%
- Average Volume (3M)
- 69.73K
- Price to Earnings (P/E)
- 15.2
- Beta (1Y)
- 1.45
- Revenue Growth
- 13.01%
- EPS Growth
- 28.70%
- Country
- Japan
- Employees
- 1,146
- Sector
- General
- Sector Strength
- 55
- Industry
- Industrial - Machinery
Iwaki Co. Ltd. Business Overview & Revenue Model
Company Description
Iwaki Co., Ltd. is a key player in the manufacturing and distribution of chemical fluid pumps and their corresponding control systems. The company primarily caters to Original Equipment Manufacturers (OEMs) across a broad spectrum of industries and a...
Iwaki Co. Ltd. Financial Statement Overview
Summary
Highly attractive financial profile featuring a fortress balance sheet, steady revenue growth, and strong net profitability, slightly offset by a minor contraction in operating margins and free cash flow conversion.
Income Statement
82Very PositiveBalance Sheet
92Very PositiveCash Flow
78Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.69B | 47.69B | 45.76B | 44.54B | 37.73B | 32.44B |
| Gross Profit | 18.77B | 18.77B | 18.20B | 18.33B | 12.92B | 11.03B |
| EBITDA | 8.05B | 7.49B | 8.15B | 7.96B | 6.09B | 3.97B |
| Net Income | 4.84B | 4.84B | 4.47B | 4.46B | 4.26B | 2.40B |
Balance Sheet | ||||||
| Total Assets | 55.84B | 55.84B | 54.15B | 49.10B | 45.25B | 38.45B |
| Cash, Cash Equivalents and Short-Term Investments | 9.98B | 9.98B | 8.88B | 8.39B | 8.93B | 8.78B |
| Total Debt | 4.06B | 4.06B | 2.76B | 2.72B | 2.73B | 2.08B |
| Total Liabilities | 14.36B | 14.36B | 16.04B | 15.58B | 16.38B | 13.20B |
| Stockholders Equity | 41.35B | 41.35B | 37.89B | 33.28B | 28.71B | 25.18B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 2.51B | 2.70B | 1.48B | 620.28M | 2.08B |
| Operating Cash Flow | 0 | 5.25B | 3.46B | 2.56B | 1.91B | 2.71B |
| Investing Cash Flow | 0 | -3.39B | -784.01M | -2.49B | -1.52B | -429.19M |
| Financing Cash Flow | 0 | -1.28B | -1.88B | -1.85B | -419.04M | -579.34M |
Iwaki Co. Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6237, the sentiment is Neutral. The current price of 3895.00 is below the 20-day moving average (MA) of 3899.00, below the 50-day MA of 3951.59, and above the 200-day MA of 3471.37, indicating a neutral trend. The MACD of -49.38 indicates Negative momentum. The RSI at 48.87 is Neutral, neither overbought nor oversold. The STOCH value of 72.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:6237.
Iwaki Co. Ltd. Peers Comparison
Overall Rating
JP:638177Outperform
JP:623770Outperform
JP:639367Neutral
JP:637665Neutral
JP:649864Neutral
JP:636357Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | JPY 67.65B | 11.49 | ― | 5.24% | 13.76% | 38.30% | |
| 70Outperform | JPY 85.32B | 15.20 | ― | 2.23% | 13.01% | 28.70% | |
| 67Neutral | JPY 12.26B | 8.84 | ― | 5.02% | 0.61% | 3.85% | |
| 65Neutral | JPY 168.44B | 10.30 | 10.86% | 1.88% | 12.76% | 63.89% | |
| 64Neutral | JPY 157.74B | 12.24 | 10.55% | 3.36% | 14.51% | 10.65% | |
| 57Neutral | JPY 65.66B | 6.04 | ― | 2.59% | -1.87% | 215.36% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:6237 | Iwaki Co. Ltd. | 3895.00 | 1564.76 | 67.15% | |
| JP:6498 | Kitz Corporation | 1817.00 | 185.48 | 11.37% | |
| JP:6376 | Nikkiso Co., Ltd. | 2759.00 | 1190.41 | 75.89% | |
| JP:6363 | Torishima Pump Mfg.Co., Ltd. | 2550.00 | 710.52 | 38.63% | |
| JP:6381 | ANEST IWATA Corp. | 1700.00 | 273.28 | 19.15% | |
| JP:6393 | Yuken Kogyo Co., Ltd. | 2989.00 | 174.21 | 6.19% |
Iwaki Co. Ltd. Corporate Events
Iwaki Revises Fiscal 2027 Earnings and Dividend Forecasts
Iwaki Co., Ltd., a Tokyo Stock Exchange Prime Market-listed company, reports sales in medical equipment, water treatment, and semiconductor/liquid crystal categories across Japan, the U.S., China, South Korea and Taiwan. It revised its fiscal 2027 fo...
Iwaki Adjusts and Completes Treasury Share Disposal for Employee Stock Plan
Iwaki Co., Ltd. has completed the disposal of treasury shares under a restricted stock incentive plan for its Employee Stock Ownership Association, following a resolution by its board in July 2026. The plan is designed to grant company shares to elig...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
